700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
Paroxysmal extreme pain disorder is an autosomal dominant disorder caused by mutation of the SCN9A gene. In most cases, the pain is relieved by carbamazepine. We report on a novel SCN9A mutation associated with carbamazepine-resistant. The proband was a 7-month-old child who suffered from typical attacks from birth onwards. Sequencing of SCN9A revealed a heterozygous c.4880T>G substitution. Identification of this novel mutation and characterization of the associated carbamazepine-resistant phenotype may facilitate diagnosis and drug development.
Nerve pain, Mutation, Paroxysmal extreme pain disorder, Behavioral Psychology, Chiari malformation, Chronic Traumatic Encephalopathy, Congenital Brain Defects, Duchenne Muscular Dystrophy, Epilepsy and Seizures, Genetic and Metabolic Disorders, Genetic Epilepsies, Headaches and Migraines, Movement Disorders, Neonatal encephalopathy, Neurodevelopmental Disorders, Neurogenetic Disorders, Neurological Complications of AIDS, Neuromuscular Disease, Pediatric Brain Tumour, Pediatric Sleep Disorders, Stroke and Perinatal Injuries